Delivery Order SPE2DR25D3003-SPE2DR26F5QH8
- Not listed
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 16, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,745.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on November 7, 2025, with completion expected by December 2, 2025. This non-set-aside, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. Benlysta (belimumab) is a specialized biologic treatment for systemic lupus erythematosus, reflecting...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,497.32 for Benlysta 200 mg/ml auto-injector on November 18, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $55,488.06 for Benlysta 200 mg/ml auto-injectors on September 17, 2025, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $12,330.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of September 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Benlysta 200 mg/mL auto-injector units, with a ceiling value of $12,994.64 and an ultimate completion date of December 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $19,491.96 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on November 5, 2025, with completion targeted for November 28, 2025. This firm fixed price, non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award is being fulfilled from AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp on October 22, 2025, for Benlysta 200 mg/mL auto-injector units. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of November 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QH8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 11, 2025. This non-competitive delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 5, 2026, under a firm fixed-price arrangement. Benlysta (belimumab) is a biologic immunosuppressant used primarily in the treatment of systemic lupus erythematosus and lupus nephritis. This delivery order represents one of numerous pharmaceutical procurements AmerisourceBergen fulfills through its comprehensive DLA prime vendor contract, which supports military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal medical supply needs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen consistently wins competitively awarded contracts across multiple therapeutic domains, demonstrating its capacity to meet specialized pharmaceutical requirements for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 12/10/25 |